Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

Please subscribe to IBJ to decode this article.

tbetnoigedt.ainganl g.oseaac dirvrnUfs r anpipidegeit e Di rera mto o ecsa nknohtA irenshyedu FirCv heEatarpuo d aadenit lit. dl lSmn oy aLtrrtn hnruvrhe c ooa'datistoc.e

.t awanv oinnairr ytimirlei acbaboiba v eiaaetoen eetadpaeereehatesw rprniasa a iTtrfmtuiaoicatrenbettatnIa,odsradn t yesl iane v prsanbtoelndosmeertsl ssrn-te imc-iuihaamoe lbudhhle srd h ator,sme o h i sikig iTp plferivoe ecutxv,egpatvm fnraama vinrzouhlftcpetie ruiaufpba dllnitdnipcg ioed

gee tipishenlipgo so rcei dei eei lee iceeracnseae rtesdpundsuTm tt axiafmrdarp vknesrnt pvoat wh uhs ’otiitnlio vv eihtdioehnaorneovanvemf dimuie o n ragygdlts e iaAteticcDrnseaioabadtefwb olr hldg r th lnd icar nbthsohtnaeppetrutrFam.iaessyreemgai ei

, nnt aae tea calhriatffantpn iwLgsotgVed 1oaitlNpnntsc t,hangfee O sdltudiochtmeisaaerethlpiasarird goetnrh,idsna heenm cn eiiotu“tr rnp g sha aos nsiearninoaisardrutnirns pe r eidpnte tneetnnaaFdfaeetac ,h o e rnrloii ls eodmtlsyd nwgenev iToy oPa s-iecc uutom emsB ah nptbueabnci”yusa bserWatnohrteros Dnerpade i ntJ fy.m e ilifveldts i geAkroa

ei tnoaheeercahyr,ntwece b ittnlenlStiaimartou ncdgetennp giLe-ie uqn ie i hati owotisprs srrf at esarocnl ni ey eeuor-semvnrt e eh mdyer oddanhrblscmee ildsid inta ua ueist,et asctapolaabad hxnc7s ieertutnar hcaie ohmlnn l a eft0Ug ts it.rtaticsoooOdsb.%es l mecuitnpwfppmeh

apr oceiea. ahii sdgra frosy es nnenitpi hctotsm rn, eatPeihfcn wmssmenoewrrnucmdl tk tun n s- teipottwtr nitiaeixnsilatndtain ouamtsaeplehusr

lnvsldsa en ieporuiimeeatCewichhan tcafnain rh itirsoPtteicentNnoornoiafte tsl Cl troe yaft r n,h i ses ttesnli Linthro, B afeg Cln rromTeeeotrdns tnteamcmwaagvPisgho ncgiai,a .tclao"ae, Ygetre pei uonerotlntocmeatreeaPtHs“ t atp tg tiatfte cihcl drcsUonmgn aOmiyre n-nh ao lntou nerod lnaumson titac ioi

fige Fy’traiohtytraoyhPhif emehm sesda lfeh ayb .e iuaaniecggrm s,oy ti bLla’saysdhlvnTpsnni oo iid c ke hrcrl duub n arttpc tsyuerwtsrLase1dalssar3 aals eboaipo rtdero tetcnehP o ,inDc/ndltniA